Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry News Roundup

This article was originally published in The Tan Sheet

Executive Summary

Reckitt looks to “friend” consumers on Facebook; InterHealth acquires 7-Keto; regulators interested in adverse event reporting; CRN tool reveals enforcement trends; FDA food advisors take on risk assessments; and more consumer health care product industry news.

You may also be interested in...



Consumer Health Sales And Earnings Roundup: Prestige, GNC, USANA, Omega Protein

Prestige would stretch distribution for European growth; GNC prioritizes increasing franchises; co-pilots at USANA helm to manage growth; Omega Protein grows on acquisition.

Consumer Health Sales And Earnings Roundup: Prestige, GNC, USANA, Omega Protein

Prestige would stretch distribution for European growth; GNC prioritizes increasing franchises; co-pilots at USANA helm to manage growth; Omega Protein grows on acquisition.

Firms Should Keep Claim-Substantiation Documents Ready For Review – FTC

A consent-order requirement that dietary supplement firms Martek and i-Health retain and make available for inspection all supporting documents for claims substantiation should be a best practice for consumer-product firms making health claims, an FTC lawyer suggests. The agency likely will dig deeper into underlying statistical analyses of studies than the peer-review panels of journals.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel